Cell Therapy Analytical Development Summit Europe, taking place from 23-25 of August in London, will bring together professionals working in CMC, QC, process development, and regulatory functions. Join your peers in person to: Learn to develop a successful potency assay to determine product activity Explore reference standards for state-of-the-art analytical development Discover new technology to […]

With two approved therapeutics and the field working to develop the next generation of IPF drugs, the opportunity to become the undisputed, most effective, and disease-modifying agent on the market has never been greater. From repairing and regenerating lung tissue to illuminating innovative clinical trial design and advance scientific progress; the 6th IPF Summit is your one-stop-shop to supercharge IPF research and drug development. […]

Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs. In collaboration with leading integrin drug developers, […]